Publishing Your Clinical Trial

  • Warren GasperEmail author
  • Michael Conte
Part of the Success in Academic Surgery book series (SIAS)


Publication of a clinical trial is the culmination of an enormous effort; one that deserves an accurate and transparent report. Although the trial protocol and statistical analysis plan serve as the framework for a clear presentation of the results, it is an arduous task to condense the thousands of design details, data points, and analyses into a concise manuscript. Appointing a publication committee to outline the manuscript, settling questions of authorship, and selecting a target journal assures timely publication of the final report. Guidelines, including the CONSORT Statement, assist in writing a report that is complete and provides maximum value to the medical community. After the initial publication, a thoughtful secondary analysis plan not only maximizes knowledge gained from trial data, it can also help mitigate bias when there are unexpected results. Developing a data sharing plan ensures that the trial data continues to be useful long after the primary and secondary analyses are completed.


Randomized clinical trial Publication standards Research design standards Clinical practice guidelines 


  1. 1.
    International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Vancouver, BC: International Committee of Medical Journal Editors; 2018. Accessed 7 May 2019.Google Scholar
  2. 2.
    Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. Scholar
  3. 3.
    Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7. Scholar
  4. 4.
    Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. Scholar
  5. 5.
    Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. Scholar
  6. 6.
    Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239. Scholar
  7. 7.
    Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, Group C. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594–604. Scholar
  8. 8.
    Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390. Scholar
  9. 9.
    Campbell MK, Piaggio G, Elbourne DR, Altman DG, Group C. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661. CrossRefPubMedGoogle Scholar
  10. 10.
    Extensions of the CONSORT Statement. CONSORT website. 2019. Accessed 7 May 2019.
  11. 11.
    Simera I, Moher D, Hoey J, Schulz KF, Altman DG. The EQUATOR Network and reporting guidelines: helping to achieve high standards in reporting health research studies. Maturitas. 2009;63(1):4–6. Scholar
  12. 12.
    The EQUATOR Network. Enhancing the quality and transparency of health research. EQUATOR Network website. 2019. Accessed 7 May 2019.
  13. 13.
    World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. Scholar
  14. 14.
    Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141(10):781–8. Scholar
  15. 15.
    Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dore C, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017;318(23):2337–43. Scholar
  16. 16.
    Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. Scholar
  17. 17.
    Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. Scholar
  18. 18.
    Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):e012799. Scholar
  19. 19.
    Collins GS, Reitsma JB, Altman DG, Moons KG, Group T. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group. Circulation. 2015;131(2):211–9. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Vascular and Endovascular SurgeryUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations